<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">78469</article-id><article-id pub-id-type="doi">10.7554/eLife.78469</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Medicine</subject></subj-group></article-categories><title-group><article-title>Trio-based whole exome sequencing in patients with suspected sporadic inborn errors of immunity: a retrospective cohort study</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-273079"><name><surname>Hebert</surname><given-names>Anne</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8945-015X</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273080"><name><surname>Simons</surname><given-names>Annet</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273081"><name><surname>Schuurs-Hoeijmakers</surname><given-names>Janneke HM</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-253778"><name><surname>Koenen</surname><given-names>Hans JPM</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273082"><name><surname>Zonneveld-Huijssoon</surname><given-names>Evelien</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273083"><name><surname>Henriet</surname><given-names>Stefanie SV</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273084"><name><surname>Schatorjé</surname><given-names>Ellen JH</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273085"><name><surname>Hoppenreijs</surname><given-names>Esther PAH</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273086"><name><surname>Leenders</surname><given-names>Erika KSM</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273087"><name><surname>Janssen</surname><given-names>Etienne JM</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-81321"><name><surname>Santen</surname><given-names>Gijs WE</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273088"><name><surname>de Munnik</surname><given-names>Sonja A</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273093"><name><surname>van Reijmersdal</surname><given-names>Simon V</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273089"><name><surname>van Rijssen</surname><given-names>Esther</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273473"><name><surname>Kersten</surname><given-names>Simone</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-0251-5564</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-200873"><name><surname>Netea</surname><given-names>Mihai G</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2421-6052</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-273091"><name><surname>Smeets</surname><given-names>Ruben L</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-56354"><name><surname>van de Veerdonk</surname><given-names>Frank L</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-1121-4894</contrib-id><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" corresp="yes" id="author-98697"><name><surname>Hoischen</surname><given-names>Alexander</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8072-4476</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-272626"><name><surname>van der Made</surname><given-names>Caspar I</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-0763-4017</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Department of Human Genetics</institution>, <institution>Radboud University Nijmegen Medical Centre</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff2"><institution content-type="dept">Department of Laboratory Medicine</institution>, <institution>Radboud University Nijmegen Medical Centre</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff3"><institution content-type="dept">Department of Genetics</institution>, <institution>University Medical Center Groningen</institution>, <addr-line><named-content content-type="city">Groningen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff4"><institution content-type="dept">Department of Pediatric Infectious Diseases and Immunology</institution>, <institution>Radboud University Nijmegen Medical Centre</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff5"><institution content-type="dept">Department of Pediatric Rheumatology and Immunology</institution>, <institution>Radboud University Nijmegen Medical Centre</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff6"><institution content-type="dept">Department of Clinical Genetics</institution>, <institution>Maastricht University Medical Centre</institution>, <addr-line><named-content content-type="city">Maastricht</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff7"><institution content-type="dept">Center for Human and Clinical Genetics</institution>, <institution>Leiden University Medical Center</institution>, <addr-line><named-content content-type="city">Leiden</named-content></addr-line>, <country>Netherlands</country></aff><aff id="aff8"><institution content-type="dept">Department of Internal Medicine</institution>, <institution>Radboud University Nijmegen Medical Centre</institution>, <addr-line><named-content content-type="city">Nijmegen</named-content></addr-line>, <country>Netherlands</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-214885"><name><surname>Yuen</surname><given-names>Tony</given-names></name><role>Reviewing editor</role><aff><institution>Icahn School of Medicine at Mount Sinai</institution>, <country>United States</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>alexander.hoischen@radboudumc.nl</email> (AH);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>17</day><month>10</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e78469</elocation-id><history><date date-type="received"><day>08</day><month>03</month><year>2022</year></date><date date-type="accepted"><day>05</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement>© 2022, Hebert et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>Hebert et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-78469-v1.pdf"/><abstract><p><bold>Background:</bold> <italic>De novo</italic> variants (DNVs) are currently not routinely evaluated as part of diagnostic whole exome sequencing (WES) analysis in patients with suspected inborn errors of immunity (IEI). </p><p><bold>Methods:</bold> This study explored the potential added value of systematic assessment of DNVs in a retrospective cohort of 123 patients with a suspected sporadic IEI that underwent patient-parent trio-based WES. </p><p><bold>Results:</bold> A (likely) molecular diagnosis for (part) of the immunological phenotype was achieved in 12 patients with the diagnostic <italic>in silico</italic> IEI WES gene panel. Systematic evaluation of rare, non-synonymous DNVs in coding or splice site regions led to the identification of 14 candidate DNVs in genes with an annotated immune function. DNVs were found in IEI genes (<italic>NLRP3</italic> and <italic>RELA</italic>) and in potentially novel candidate genes, including <italic>PSMB10</italic>, <italic>DDX1</italic>, <italic>KMT2C</italic> and <italic>FBXW11</italic>. The <italic>FBXW11</italic> canonical splice site DNV was shown to lead to defective RNA splicing, increased NF-κB p65 signalling, and elevated IL-1β production in primary immune cells extracted from the patient with autoinflammatory disease.&lt; </p><p><bold>Conclusions:</bold> Our findings in this retrospective cohort study advocate the implementation of trio-based sequencing in routine diagnostics of patients with sporadic IEI. Furthermore, we provide functional evidence supporting a causal role for <italic>FBXW11</italic> loss-of-function mutations in autoinflammatory disease. </p><p><bold>Funding:</bold> This research was supported by grants from the European Union, ZonMW and the Radboud Institute for Molecular Life Sciences.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000781</institution-id><institution>European Research Council</institution></institution-wrap></funding-source><award-id>No. 833247</award-id><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>Spinoza Grant</award-id><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Radboud Institute for Molecular Life Sciences</institution></institution-wrap></funding-source><award-id>Internal grant</award-id><principal-award-recipient><name><surname>Netea</surname><given-names>Mihai G</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001826</institution-id><institution>ZonMw</institution></institution-wrap></funding-source><award-id>Vidi</award-id><principal-award-recipient><name><surname>van de Veerdonk</surname><given-names>Frank L</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>HDM-FUN</award-id><principal-award-recipient><name><surname>van de Veerdonk</surname><given-names>Frank L</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100010663</institution-id><institution>H2020 European Research Council</institution></institution-wrap></funding-source><award-id>Solve-RD (No. 779257)</award-id><principal-award-recipient><name><surname>Hoischen</surname><given-names>Alexander</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Frank L van de Veerdonk, Reviewing editor, <italic>eLife</italic>.</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: Patients and their parents provided written informed consent for in silico inborn errors of immunity whole exome sequencing gene panel analysis with or without exome-wide variant analysis in line with the diagnostic procedure and clinical question, as approved by the Medical Ethics Review Committee Arnhem-Nijmegen (2011/188 and 2020-7142). This research is in compliance with the principles of the Declaration of Helsinki.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>The code used to filter DNA sequencing data for candidate de novo mutations (DNMs) and to generate output files is provided in Figure 1 - source code 1. Source data linked to Figure 1 - figure supplement 1 is provided as an additional, numerical data file. Source data for candidate DNM evaluation is provided in Figure 1 - source data 2. Source data linked to Figure 2 - figure supplement 1A is an uncropped, raw gel image used to create this figure. Source data linked to Figure 2B-D is provided as an additional, numerical data file. Raw DNA sequencing data of patients are not publicly available as it is confidential human subject data that would compromise anonymity. Researchers that are interested to access the sequencing data of our cohort are advised to contact the corresponding author, A. Hoischen (alexander.hoischen@radboudumc.nl). Anonymized subject data will be shared on request from qualified investigators for the purposes of replicating procedures and results, and for other non-commercial research purposes within the limits of participants' consent. Any data sharing will also require evaluation of the request by the regional Arnhem and Nijmegen Ethics Committee and the signature of a data transfer agreement (DTA).</p></sec><supplementary-material><ext-link xlink:href="elife-78469-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>